Reaction

Maternal Exposure During Delivery reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 959 reports · 38 co-occurring drugs

As of the last recalculation, Maternal Exposure During Delivery appears in 959 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 793.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Bupivacaine252793.7815.8
Misoprostol4297.998.3
Rocuronium Bromide4995.195.5
Lidocaine Hydrochloride19185.685.9
Lidicaine15380.680.8
Burn Relief15380.680.8
Lidocaine Hydrochloride And Epinephrine15380.480.7
Lidocaine, Menthol15379.579.7
Lidocaine Hydrochloride And Epinephrine Bitartrate16077.978.1
Cefazolin3073.673.9
Tranexamic Acid2972.973.2
Lidocaine 4%15472.973.1
Fentanyl23969.870.0
Lidocaine15468.168.3
Cefazolin Sodium3565.465.6
Sevoflurane2361.561.7
Labetalol3457.457.5
Magnesium Sulfate In Water For3052.652.7
Magnesium Sulfate Heptahydrate3051.651.7
Magnesium Sulfate3051.551.6
Propofol7749.649.8
Norepinephrine1939.339.4
Adrenalinum6938.838.9
Morphine11136.436.4
Norepinephrine Bitartrate2335.535.6
Ampicillin1334.534.6
Ampicillin Sodium1334.534.6
Nevirapine1229.229.3
Cefuroxime1528.928.9
Epinephrine7225.725.8
Midazolam2623.023.0
Midazolam Hydrochloride2621.521.5
Atropine821.121.1
Atropine Sulfate918.218.3
Fentanyl Citrate1417.217.3
Sodium Chloride5716.616.6
Metoclopramide3614.714.8
Copper52.52.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.